121 related articles for article (PubMed ID: 4037914)
1. Thromboembolism in patients with aortic porcine bioprostheses.
David TE; Ho WI; Christakis GT
Ann Thorac Surg; 1985 Sep; 40(3):229-33. PubMed ID: 4037914
[TBL] [Abstract][Full Text] [Related]
2. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
3. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
5. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
6. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
7. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis.
Nuñez L; Gil Aguado M; Larrea JL; Celemín D; Oliver J
Ann Thorac Surg; 1984 Jan; 37(1):84-7. PubMed ID: 6691742
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
[TBL] [Abstract][Full Text] [Related]
9. Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis.
Nuñez L; Aguado MG; Celemín D; Iglesias A; Larrea JL
Ann Thorac Surg; 1982 Apr; 33(4):354-8. PubMed ID: 7073379
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
11. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic and haemorrhagic risk in mechanical and biological aortic prostheses.
Farah E; Enriquez-Sarano M; Vahanian A; Houlegatte JP; Boubaker A; Roger V; Acar J
Eur Heart J; 1984 Oct; 5 Suppl D():43-7. PubMed ID: 6519101
[TBL] [Abstract][Full Text] [Related]
13. Early and late risk of aortic valve replacement. A 12 year concomitant comparison of the porcine bioprosthetic and tilting disc prosthetic aortic valves.
Cohn LH; Allred EN; DiSesa VJ; Sawtelle K; Shemin RJ; Collins JJ
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):695-705. PubMed ID: 6492838
[TBL] [Abstract][Full Text] [Related]
14. Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Whitlock RP; Eikelboom JW
J Am Coll Cardiol; 2012 Sep; 60(11):978-80. PubMed ID: 22921974
[No Abstract] [Full Text] [Related]
15. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
16. Long-term durability of the Hancock porcine bioprosthesis following combined mitral and aortic valve replacement: an 11-year experience.
Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Talenti E; Gallucci V
Ann Thorac Surg; 1987 Aug; 44(2):139-44. PubMed ID: 3619538
[TBL] [Abstract][Full Text] [Related]
17. Impact of aspirin use in the incidence of thromboembolic events after bioprosthesis replacement in patients with rheumatic disease.
Durães AR; Durães MA; Correia LC; Fernandes AM; Aras Junior R
Rev Bras Cir Cardiovasc; 2013; 28(3):347-52. PubMed ID: 24343684
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant therapy in children with prosthetic valves.
Rao PS; Solymar L; Mardini MK; Fawzy ME; Guinn G
Ann Thorac Surg; 1989 Apr; 47(4):589-92. PubMed ID: 2712632
[TBL] [Abstract][Full Text] [Related]
19. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
Christersson C; James SK; Lindhagen L; Ahlsson A; Friberg Ö; Jeppsson A; Ståhle E
Heart; 2020 Jun; 106(11):838-844. PubMed ID: 31757813
[TBL] [Abstract][Full Text] [Related]
20. Midterm outcome after aortic root replacement with stentless porcine bioprostheses.
Ennker IC; Albert A; Dalladaku F; Rosendahl U; Ennker J; Florath I
Eur J Cardiothorac Surg; 2011 Aug; 40(2):429-34. PubMed ID: 21277220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
